Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Prediction: Scube3 is never coming out

      in Research/Science  6 upvotes 2 years ago
      Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.

      community March 21st vs July 9th! Topical fin, minox, latanoprost, and biotin

      in Progress Pictures  119 upvotes 2 years ago
      The user "cooler1082" shared their progress pictures for hair loss after using topical finasteride, minoxidil, latanoprost, and biotin. Other users commented on the positive results and asked about the specific dosages used. One user mentioned that latanoprost is an eye medication that has shown some potential for treating hair loss.

      community Alfatradiol Experience (2 months)

      in Treatment  12 upvotes 5 years ago
      User experienced side effects from oral finasteride and tried topical Alfatradiol for hair loss. Alfatradiol provided maintenance without significant regrowth, and user suggests it as an alternative for those struggling with finasteride side effects.

      community Spironolactone and pregnancy planning

      in Female  2 upvotes 11 months ago
      A user with AGA uses topical spironolactone 2% due to side effects from the oral form and is concerned about its use during conception and breastfeeding. They seek alternatives to prevent AGA relapse while planning pregnancy and after childbirth.

      community Any chemists want to manufacture PP405 / JXL069? (Steps inside)

      in Research/Science  112 upvotes 11 months ago
      The conversation discusses the potential of PP405 as a hair loss treatment, with some users expressing skepticism and others hopeful about its development. There is also mention of other treatments like Minoxidil, Finasteride, and Pyrilutamide, with users debating the effectiveness and safety of self-experimentation versus waiting for clinical trial results.